Get started
Author

Richard D’Anna

Observed names: R. D’Anna, Richard D'Anna, Richard D'anna, Richard E D’Anna
OpenAlex ID: A5113074972
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
2021 · Renato D. Lopes, Celestia S. Higano, et al. · Circulation · 156
One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume ® Drug-Coated Balloon for Anterior Urethral Strictures
2021 · Sean P. Elliott, Karl Coutinho, et al. · The Journal of Urology · 81
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
2023 · Steven A. Kaplan, Jared Moss, et al. · The Journal of Urology · 48
Optilume drug‐coated balloon for anterior urethral stricture: 2‐year results of the ROBUST III trial
2023 · Maia E. VanDyke, Allen F. Morey, et al. · BJUI Compass · 44
Clinical Outcomes in Men with Prostate Cancer who Selected Active Surveillance Using a Clinical Cell Cycle Risk Score
2019 · Sanjeev Kaul, Kirk J Wojno, et al. · Personalized Medicine · 16
PDF
Hereditary cancer risk assessment and genetic testing in the community urology practice setting
2022 · Neal D. Shore, Lauren Lenz, et al. · The Prostate · 3
Mp56-07 Interim Results for the Robust Iii Trial Evaluating the Optilume Drug Coated Balloon for Anterior Urethral Strictures
2021 · Sean Elliott, Jessica DeLong, et al. · The Journal of Urology · 2
Lba02-03 Can Turbt Be Avoided? Primary Chemoablation With a Reverse Thermal Gel Containing Mitomycin (ugn-102) in Patients With Low Grade Intermediate Risk Non-muscle Invasive Bladder Cancer
2020 · William Huang*, Kent Chevli, et al. · The Journal of Urology · 2
Mp06-15 the Optilume® Drug Coated Balloon for Recurrent Anterior Urethral Strictures: Robust Iii Study 4-year Interim Results
2024 · Sean Elliott, Ramon Virasoro, et al. · The Journal of Urology · 1
Hereditary cancer risk assessment in the community urology practice setting.
2022 · Neal D. Shore, Lauren Lenz, et al. · Journal of Clinical Oncology · 1
Reply by Authors
2021 · Sean P. Elliott, Karl Coutinho, et al. · The Journal of Urology · 1
Semen RNA-Based Biomarkers for Prostate Cancer Detection and Risk Stratification: A Prospective Multicenter Validation Study
2026 · Duncan H. Whitney, Matthew Clay, et al. · The Journal of Urology
Pd04-12 Semen-based Transcriptomic Biomarkers for Prostate Cancer Detection
2025 · Duncan H. Whitney, Matthew R. Clay, et al. · The Journal of Urology
Reply by Authors
2023 · Steven A. Kaplan, Jared Moss, et al. · The Journal of Urology
Pd41-03 12-month Outcomes From a Randomized, Sham Controlled Study Evaluating a Novel Drug Coated Balloon for the Treatment of Bph
2023 · Steven A. Kaplan, Jared Moss, et al. · The Journal of Urology
The Optilume drug coated balloon for recurrent anterior urethral strictures: ROBUST III study 2 year results
2022 · S. Elliott, J. DeLong, et al. · European Urology Open Science
PD43-02 PRIMARY CHEMOABLATION OF LOW-GRADE INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER USING UGN-102, A MITOMYCIN-CONTAINING REVERSE THERMAL GEL (OPTIMA II): A PHASE 2b, OPEN-LABEL, SINGLE-ARM TRIAL
2021 · Kent Chevli, Neal Shore, et al. · The Journal of Urology
ROBUST III: Interim results of a randomized trial of the optilume drug coated balloon for anterior urethral strictures
2021 · R. Virasoro, J. Delong, et al. · European Urology
Outcomes of men with prostate cancer managed with active surveillance and tested with clinical cell-cycle risk score.
2019 · Behfar Ehdaie, Sanjeev Kaul, et al. · Journal of Clinical Oncology
Phase IV evaluation of clinical outcomes of PROCRIT in anemic cancer patients receiving chemotherapy
1994 · Ronald Bukowski, John A. Glaspy, et al.
Works count: 20
Citation count: 355
H-index: 5
I10-index: 5
Year
Topic
Type